The effect of Ramadan fasting on glycaemic control in insulin dependent diabetic patients: A literature review

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 11, Issue 1, 2017, Pages 83-87

  Alabbood, Majid H ^a,b   Ho, Kenneth W ^a   Simons, Mary R ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF BASRAH   (Iraq)

Author keywords

Diabetes mellitus; Insulin dependent diabetes; Ramadan

Indexed keywords

FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT;

BIBLIOGRAPHIC DATABASE; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; DIET RESTRICTION; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; ISLAM; MEDICAL RECORD; PREGNANT WOMAN; PRIORITY JOURNAL; RAMADAN FASTING; REVIEW; ADVERSE EFFECTS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FASTING; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; ISLAM;

EID: 84996848275     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2016.06.028     Document Type: Review

References (18)

1. [1] Al-Khawari, M., Al-Ruwayeh, A., Al-Doub, K., Allgrove, J., Adolescents on basal-bolus insulin can fast during Ramadan. Pediatr Diabetes 11:2 (2010), 96–100.
2. [2] Bin-Abbas, B.S., Insulin pump therapy during Ramadan fasting. Ann Saudi Med 28:4 (2007), 305–306.
3. [3] Hui, E., Bravis, V., Salih, S., Hassanein, M., Devendra, D., Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan. Int J Clin Pract 64:8 (2010), 1095–1099.
4. [4] Kadiri, A., Al-Nakhi, A., El-Ghazali, S., Jabbar, A., Al Arouj, M., Akram, J., et al. Treatment of type 1 diabetes with insulin lispro during Ramadan. Diabetes Metab 27:4 I (2001), 482–486.
5. [5] Mattoo, V., Milicevic, Z., Malone, J., Schwarzenhofer, M., Ekangaki, A., Levitt, L., et al. A comparison of insulin lispro Mix25™ and human insulin 30/70 in the treatment of Type 2 diabetes during Ramadan. Diabetes Res Clin Pract 59:2 (2003), 137–143.
6. [6] Ahmadani, M.Y., Riaz, M., Fawwad, A., Hydrie, M.Z.I., Hakeem, R., Basit, A., Glycaemic trend during Ramadan in fasting diabetic subjects: a study from Pakistan. Pak J Biol Sci 11:16 (2008), 2044–2047.
7. [7] Ahmedani, M.Y., Alvi, S.F.D., haque, M.S.U., Fawwad, A., Basit, A., Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan. J Diabetes Metab Disord, 13(1), 2014.
8. [8] Ahmedani, M.Y., Haque, M.S., Basit, A., Fawwad, A., Alvi, S.F.D., Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education. Diabet Med 29:6 (2012), 709–715.
9. [9] Alalwan, I., Banyan, A.A., Effects of Ramadan fasting on children with type 1 diabetes. Int J Diabetes Mellit 2:2 (2010), 127–129.
10. [10] Benbarka, M.M., Khalil, A.B., Beshyah, S.A., Marjei, S., Awad, S.A., Insulin pump therapy in moslem patients with type 1 diabetes during ramadan fasting: an observational report. Diabetes Technol Ther 12:4 (2010), 287–290.
11. [11] Cesur, M., Corapcioglu, D., Gursoy, A., Gonen, S., Ozduman, M., Emral, R., et al. A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. Diabetes Res Clin Pract 75:2 (2007), 141–147.
12. [12] Khalil, A.B., Beshyah, S.A., Abu Awad, S.M., Benbarka, M.M., Haddad, M., Al-Hassan, D., et al. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study. Diabetes Technol Ther 14:9 (2012), 813–818.
13. [13] Kassem, H.S., Zantout, M.S., Azar, S.T., Insulin therapy during Ramadan fast for Type 1 diabetes patients. J Endocrinol Invest 28:9 (2005), 802–805.
14. [14] Lessan, N., Hannoun, Z., Hasan, H., Barakat, M.T., Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM). Diabetes Metab J 41:1 (2015), 28–36.
15. [15] Nor Azlin, M.I., Adam, R., Sufian, S.S., Wahab, N.A., Mustafa, N., Kamaruddin, N.A., et al. Safety and tolerability of once or twice daily neutral protamine hagedorn insulin in fasting pregnant women with diabetes during Ramadan. J Obstet Gynaecol Res 37:2 (2011), 132–137.
16. [16] Salti, I., Benard, E., Detournay, B., Bianchi-Biscay, M., Le Brigand, C., Voinet, C., et al. A population-based study of diabetes and its characteristics during the fasting month of ramadan in 13 countries: results of the epidemiology of diabetes and ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 27:10 (2004), 2306–2311.
17. [17] Benaji, B., Mounib, N., Roky, R., Aadil, N., Houti, I., Moussamih, S., et al. Diabetes and Ramadan: review of the literature. Diabetes Res Clin Pract 73:2 (2006), 117–125.
18. [18] Armbruster, D.A., Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 33:12 (1987), 2153–2163.